Methadone Maintenance Therapy (MMT) and Alternatives in Opioid Use Disorder: Reviewing the latest advancements, outcomes, and challenges in substitutional therapy for opioid addiction - literature review
DOI:
https://doi.org/10.12775/JEHS.2024.58.014Keywords
opioid addiction, methadone, mmt, buprenorphine, opioid use disorderAbstract
Introduction and Purpose: Opioid addiction is a serious challenge for public health worldwide, and methadone maintenance therapy (MMT) is a key therapeutic approach. This review intends to provide an up-to-date summary of the pathophysiology, clinical manifestation, diagnostic techniques, and treatment options for Opioid Use Disorder.
Materials and methods: The literature available in PubMed, Scopus, and Google Scholar databases was reviewed using the following keywords: "MMT," "methadone maintenance therapy", “maintenance therapy”, "opioid use disorder", "opioid addiction," "methadone”, ”naloxone” “naltrexone”, and “buprenorphine”.
State of Knowledge: This review examines current approaches in maintenance therapy for Opioid Use Disorder (OUD). In the study, we focus on treatments using methadone, buprenorphine, naloxone, and naltrexone. It focuses on recent advancements, comparing the effectiveness, safety, and patient outcomes of these therapies. Key challenges in treatment accessibility and implementation are also discussed, providing an updated overview of the field and identifying areas for future research in opioid addiction therapy.
Conclusion: There is a series of studies researching the psychological and behavioral problems associated with opioid addiction. This research has given medical practitioners valuable guidance on effective management techniques. According to the authors, compared to other alternative treatment methods, methadone maintenance therapy (MMT) is still considered the most effective pharmacotherapeutic method in the treatment of opioid addiction. Nevertheless, ongoing research is essential to improve diagnostic processes, develop innovative therapies, and enhance the overall quality of care for those affected by these challenges.
References
World Health Organization. Study to prevent deaths from opioid overdose shows promising results. WHO; 2021. Accessed November 24, 2023. https://www.who.int/news/item/06-08-2021-study-to-prevent-deaths-from-opioid-overdose-shows-promising-results
European Monitoring Centre for Drugs and Drug Addiction. Heroin and other opioids – The current situation in Europe. EMCDDA; 2023. Accessed November 24, 2023 https://www.emcdda.europa.eu/publications/european-drug-report/2023_en
Klimaszyk D, Kołaciński Z, Szajewski J. Opioids. In: Small Szczeklik. Updated: August 10, 2023. Verified: August 10, 2023. Available at: https://www.mp.pl/interna/chapter/B16.II.20.8.9. Accessed November 25, 2023.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013:541.
Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24(2):97–129. doi:10.1016/S0893-133X(00)00195-0. PMID: 11120394.
Przewłocki R. Mechanisms of opioid analgesics addiction. Palliat Med Pract. 2017;11(2):55-60. Published online October 12, 2017. Available at: https://journals.viamedica.pl/palliative_medicine_in_practice/article/view/55509
Kreek MJ, Levran O, Reed B, et al. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest. 2012;122(10):3387–3393. doi:10.1172/JCI60390. PMID: 23023708.
Murtagh FEM, Chai M-O, Donohoe P, Edmonds PM, Higginson IJ. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother. 2007;21(2):5-16. doi:10.1080/15360280802537225.
National Bureau for Drug Prevention. Report on the State of Drug Addiction 2020. Warsaw: National Bureau for Drug Prevention; 2020.
Ferrari A, Coccia CPR, Bertolini A, Sternieri E. Methadone—metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004;50(6):551-559.
Inturrisi CE, Verebely K. The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther. 1972;13(5):633-637.
Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41:1153-1193.
Saxon AJ, Ling W, Hillhouse M, et al. Medication-assisted treatment for opioid addiction: methadone and buprenorphine. J Food Drug Anal. 2013;21(4):S69-S72.
Ling W, Casadonte P, Bigelow G, et al. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA. 2010;304(14):1576-1583.
Comer SD, Sullivan MA, Yu E, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63(2):210-218
Kakko, Johan, et al. "1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial." The Lancet 361.9358 (2003): 662-668.
Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone--metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004;50(6):551-559. doi:10.1016/j.phrs.2004.05.002
Saxon, Andrew J., et al. "Buprenorphine/naloxone and methadone effects on laboratory indices of liver health: a randomized trial." Drug and alcohol dependence 128.1-2 (2013): 71-76.
Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2):CD002207. Published 2014 Feb 6. doi:10.1002/14651858.CD002207.pub4
Harrison TK, Kornfeld H, Aggarwal AK, Lembke A. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. Anesthesiol Clin. 2018;36(3):345-359. doi:10.1016/j.anclin.2018.04.002
Ekhtiari H, Tavakoli H, Addolorato G, et al. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neurosci Biobehav Rev. 2019;104:118-140
Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55(2):187-199. doi:10.1016/j.neuron.2007.06.026.
Ridding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci. 2007;8(7):559-567.
O'Shea J, Walsh V. Transcranial magnetic stimulation. Curr Biol. 2007;17(6):R196-R199.
Lefaucheur JP. Transcranial magnetic stimulation. Handb Clin Neurol. 2019;160:559-580.
Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2(3):145-156.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039.
Wu F, et al. Methadone maintenance treatment in China: perceived challenges from the perspectives of service providers and patients. J Public Health. 2013;35(2):206-212.
Preston KL, Umbricht A, Epstein DH. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch Gen Psychiatry. 2000;57(4):395-404.
Hughes RA. ‘It’s like having half a sugar when you were used to three’—drug injectors’ views and experiences of substitute drug prescribing inside English prisons. Int J Drug Policy. 2000;10(6):455-466.
Sun Y, Bao Y, Kosten T, Strang J, Shi J, Lu L. Challenges to opioid use disorders during COVID‐19. Am J Addict. 2020;29(3):174.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Karolina Koszyczarek, Maja Kotowska, Wiktoria Zamirska, Albin Ziemiański, Katarzyna Zięba, Anna Zygmunt, Paweł Smuszkiewicz-Różański, Gabriela Różańska-Smuszkiewicz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 451
Number of citations: 0